Atara Biotherapeutics Inc (NAS:ATRA)
$ 8.42 +0.20 (+2.42%) Market Cap: 75.87 Mil Enterprise Value: 77.60 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 32/100

Atara Biotherapeutics Inc Annual Shareholders Meeting Transcript

Jun 09, 2026 / 04:00PM GMT
Release Date Price: $9.77 (+1.98%)
Anhco Nguyen
Atara Biotherapeutics Inc - President, Chief Executive Officer, Director

Good morning. I'm Anhco Cokey Nguyen, and I am the President and Chief Executive Officer and a member of the board of Atara Biotherapeutics. I'm very happy to welcome you to the Atara Biotherapeutics 2026 Annual Meeting of Shareholders.

Before I call the meeting to order, I'd like to introduce to you the members of the board and members of the business team who are with us today via teleconference.

The members of the board with us virtually today are Greg Ciongli, Chair of the Board; Matthew Fust; William Heiden; James Huang; and Nachi Subramanian. The officers of the company with us virtually today are Yanina Grant-Huerta, Chief Accounting Officer; James Sesic, Senior Vice President, Regulatory Affairs; as well as John Chao, our Head of Legal.

I would also like to introduce Sean Kennedy of Deloitte Touche LLP, the company's independent registered public accounting firm; and Carlton Fleming of Sidley Austin LLP, the company's outside legal counsel, who are also in attendance virtually and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot